Logo - Business Development Bank of Canada - BDC
GeminX logo
Exited company

GeminX

Details
Region
Quebec
Industry sector
Biotechnology
Investment year
2001
Fund
Healthcare Venture Fund
Learn more
Lead
Ela Borenstein - Vice president, venture capital at BDC
Ela Borenstein

Vice President

View profile
About the company

Gemin X specialized in the discovery and development of novel therapeutics that modulate apoptosis, the body's natural ability to destroy diseased or damaged cells, in life-threatening diseases. The company is also applying its apoptotic platforms to develop additional products. Apoptosis is an important and normal biological process that plays a vital role in the physiological maintenance of a variety of tissues in the body.

Cephalon acquired Gemin X.